Emerging Markets
Navigating Regulatory Challenges in Emerging Regions
If you’re looking for new ways to gain development efficiencies, you may be considering the advantages of conducting clinical trials in emerging markets. Non-traditional regions such as India, China, Africa, Eastern Europe, the Middle East and Australia are increasingly on the short list when selecting trial locations. But navigating the diverse regulatory standards and timelines takes a deep understanding of these regions. To learn more about how you can gain the edge in your clinical trials, watch the webcast above.
In addition to the five experts in this webcast, Quintiles offers you access to over 200 professionals who know the local regulatory environment in these regions and others. With staff on the ground on six continents and over 50 countries, we know you need more than global knowledge. You need local expertise with a global footprint. Contact us before your next trial to get the in-depth information you need.
To learn more about this growing trend, we share some of our recent insights and experience in emerging markets:
- Fact sheets on specific emerging markets:
- Case studies on projects in emerging markets:
- Expanding presence in Africa - New Ghana office